Search research articles
Contact Us
Filters
Showing results (101-110 of 154) with videos related to
Page
of 16
Sort By:
European Journal of Gastroenterology & Hepatology
|
November 8, 2008
Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers
Christophe Renou, Jean-François Cadranel, Alexandre Pariente, et al.
Journal of Medical Virology
|
October 29, 2010
Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy)
Philippe Halfon, Sophie Pérusat, Marc Bourlière, et al.
Journal of Clinical Microbiology
|
November 24, 2006
Prospective evaluation of the Hybrid Capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance
Philippe Halfon, Elisabeth Trepo, Gilles Antoniotti, et al.
Clinics and Research in Hepatology and Gastroenterology
|
July 19, 2014
Impact of IL28B on the treatment decision in naïve and experienced patients with genotype 1 and 4 chronic hepatitis C in real-life clinical practice: a prospective multicenter cohort
Philippe Halfon, Denis Ouzan, Tarik Asselah, et al.
Rheumatology (Oxford, England)
|
November 29, 2019
Paradoxical association between blood modular interferon signatures and quality of life in patients with systemic lupus erythematosus
Julie Seguier, Elisabeth Jouve, Mickaël Bobot, et al.
Plos One
|
June 29, 2026
Circulating biomarkers of bronchoalveolar injury help predict the need for mechanical ventilation in patients with moderate to severe COVID-19 pneumonia: A prospective cohort study
Jérôme Allardet-Servent, Nathalie Hezard, Christel Pissier, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
March 14, 2016
Clinical relevance of the HCV protease inhibitor-resistant mutant viral load assessed by ultra-deep pyrosequencing in treatment failure
Sofiane Mohamed, Marc Bourliere, Souad Benali, et al.
Journal of Hepatology
|
December 13, 2006
Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C
Philippe Halfon, Yannick Bacq, Anne De Muret, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 22, 2008
Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C
Paul Calès, Victor de Ledinghen, Philippe Halfon, et al.
Clinical Biochemistry
|
June 13, 2006
Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis
Damien Sène, Nicholas Limal, Djamila Messous, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 154) with videos related to
Sort By:
Page
of 16
European Journal of Gastroenterology & Hepatology
|
November 8, 2008
Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers
Christophe Renou, Jean-François Cadranel, Alexandre Pariente, et al.
Journal of Medical Virology
|
October 29, 2010
Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy)
Philippe Halfon, Sophie Pérusat, Marc Bourlière, et al.
Journal of Clinical Microbiology
|
November 24, 2006
Prospective evaluation of the Hybrid Capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance
Philippe Halfon, Elisabeth Trepo, Gilles Antoniotti, et al.
Clinics and Research in Hepatology and Gastroenterology
|
July 19, 2014
Impact of IL28B on the treatment decision in naïve and experienced patients with genotype 1 and 4 chronic hepatitis C in real-life clinical practice: a prospective multicenter cohort
Philippe Halfon, Denis Ouzan, Tarik Asselah, et al.
Rheumatology (Oxford, England)
|
November 29, 2019
Paradoxical association between blood modular interferon signatures and quality of life in patients with systemic lupus erythematosus
Julie Seguier, Elisabeth Jouve, Mickaël Bobot, et al.
Plos One
|
June 29, 2026
Circulating biomarkers of bronchoalveolar injury help predict the need for mechanical ventilation in patients with moderate to severe COVID-19 pneumonia: A prospective cohort study
Jérôme Allardet-Servent, Nathalie Hezard, Christel Pissier, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
March 14, 2016
Clinical relevance of the HCV protease inhibitor-resistant mutant viral load assessed by ultra-deep pyrosequencing in treatment failure
Sofiane Mohamed, Marc Bourliere, Souad Benali, et al.
Journal of Hepatology
|
December 13, 2006
Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C
Philippe Halfon, Yannick Bacq, Anne De Muret, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 22, 2008
Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C
Paul Calès, Victor de Ledinghen, Philippe Halfon, et al.
Clinical Biochemistry
|
June 13, 2006
Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis
Damien Sène, Nicholas Limal, Djamila Messous, et al.
Page
of 16